Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

Objective: Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility tha...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucia Berti (Author), Martin Irmler (Author), Marty Zdichavsky (Author), Tobias Meile (Author), Anja Böhm (Author), Norbert Stefan (Author), Andreas Fritsche (Author), Johannes Beckers (Author), Alfred Königsrainer (Author), Hans-Ulrich Häring (Author), Martin Hrabě de Angelis (Author), Harald Staiger (Author)
Format: Book
Published: Elsevier, 2015-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available